RNA Assays for Endometriosis Detection and Diagnosis

Part of paid clinical trials in Branford, Connecticut.

Sponsor
Wren Laboratories LLC
Study ID
NCT06907303
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
FEMALE
Age
20 Years - 35 Years
Healthy Volunteers
Not accepted

Interventions

  • EndoDx — DIAGNOSTIC_TEST
    PCR assay for Endometriosis diagnosis

Study Details

Endometriosis is a common disease that affects up to 10% of women of reproductive age. Diagnosis, however, is typically delayed (up to 12 years) and is usually made after surgery. A key unmet need therefore is an accurate biomarker that can be used to detect the disease early. This study is a prospective trial to identify candidate mRNA-markers which can be used to aid in the diagnosis of this disease. It is a discovery/validation study that will identify and confirm a gene expression panel that is specific for endometriosis and provides a non-invasive tool for future use.

Key Dates

Start date
Jan 1, 2024
Status verified
Mar 2025
Primary completion
Aug 31, 2025
Completion
Dec 31, 2026

Study Design

Enrollment
400 participants (estimated)

Arms

  • Arm: Endometriosis
    Women with suspected endometriosis undergoing laparoscopy to provide tissue for pathological diagnosis of the disease.
  • Arm: Control
    Women undergoing surgery for benign cervical disease.

Primary Outcome Measure

Develop a gene signature that detects endometriosis [ Time Frame: 12-18 months ]

Locations (1)

FacilityCityStateZIPSite coordinators
Wren LaboratoriesBranfordConnecticut06405-

Find similar trials in Branford, CT

By condition
Endometriosis
By specialty
Women's healthFertility
By research site
Wren Laboratories· Branford, CT

Related Studies